WO2008059018A3 - Vaccin pour vacciner des espèces félines et canines contre le virus de la grippe - Google Patents

Vaccin pour vacciner des espèces félines et canines contre le virus de la grippe Download PDF

Info

Publication number
WO2008059018A3
WO2008059018A3 PCT/EP2007/062392 EP2007062392W WO2008059018A3 WO 2008059018 A3 WO2008059018 A3 WO 2008059018A3 EP 2007062392 W EP2007062392 W EP 2007062392W WO 2008059018 A3 WO2008059018 A3 WO 2008059018A3
Authority
WO
WIPO (PCT)
Prior art keywords
influenza virus
vaccine
felines
vaccinating
type
Prior art date
Application number
PCT/EP2007/062392
Other languages
English (en)
Other versions
WO2008059018A2 (fr
Inventor
Fengsheng Lin
Ian Tarpey
Original Assignee
Intervet Int Bv
Fengsheng Lin
Ian Tarpey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv, Fengsheng Lin, Ian Tarpey filed Critical Intervet Int Bv
Publication of WO2008059018A2 publication Critical patent/WO2008059018A2/fr
Publication of WO2008059018A3 publication Critical patent/WO2008059018A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La présente invention concerne un vaccin pour vacciner des espèces félines et canines contre le virus de la grippe, comprenant un virus de la grippe inactivé du type A (H5). Un vaccin selon l'invention vise à protéger les animaux contre la maladie provoquée par une infection par un virus de la grippe (aviaire), notamment de la grippe du type A (H5). De plus, le vaccin vise à empêcher les chats ou les chiens d'excréter des quantités substantielles d'un tel virus dans l'environnement, au cas où ils deviendraient infectés. Un vaccin selon l'invention peut être basé sur n'importe quelle souche appropriée du virus de la grippe du type A (H5), par exemple H5N2, H5N3 or H5N6.
PCT/EP2007/062392 2006-11-15 2007-11-15 Vaccin pour vacciner des espèces félines et canines contre le virus de la grippe WO2008059018A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06124162 2006-11-15
EP06124162.6 2006-11-15

Publications (2)

Publication Number Publication Date
WO2008059018A2 WO2008059018A2 (fr) 2008-05-22
WO2008059018A3 true WO2008059018A3 (fr) 2008-08-28

Family

ID=37719179

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/062392 WO2008059018A2 (fr) 2006-11-15 2007-11-15 Vaccin pour vacciner des espèces félines et canines contre le virus de la grippe

Country Status (1)

Country Link
WO (1) WO2008059018A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7674469B2 (en) 2006-10-25 2010-03-09 Internet International B.V. Feline influenza vaccine and method of use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006027698A1 (fr) * 2004-09-09 2006-03-16 Novartis Vaccines And Diagnostics Gmbh & Co Kg. Reduction de risques iatrogenes potentiels associes aux vaccins contre la grippe

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006027698A1 (fr) * 2004-09-09 2006-03-16 Novartis Vaccines And Diagnostics Gmbh & Co Kg. Reduction de risques iatrogenes potentiels associes aux vaccins contre la grippe

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
"Frequently asked questions with regard to the Avian flu, answered by Intervet International", 1 March 2006, INTERVET INTERNATIONAL, XP002473278 *
HALPERIN S A ET AL: "Safety and immunogenicity of a new influenza vaccine grown in mammalian cell culture", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 16, no. 13, August 1998 (1998-08-01), pages 1331 - 1335, XP004124601, ISSN: 0264-410X *
HORIMOTO ET AL: "The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 24, no. 17, 24 April 2006 (2006-04-24), pages 3669 - 3676, XP005353720, ISSN: 0264-410X *
INTERVET INTERNATIONAL: "Intervet liefert Impfstoff gegen Aviäre Influenza ("Vogelgrippe") an französische Regierung", INTERNET ARTICLE, 16 February 2006 (2006-02-16), XP002420406, Retrieved from the Internet <URL:http://www.intervet.com/news/2006-02-16_-_intervet_liefert_impfstoff_gegen_aviaere_influenza.asp> [retrieved on 20070214] *
INTERVET INTERNATIONAL: "Intervet to support European Zoos", INTERNET ARTICLE, 21 November 2005 (2005-11-21), XP002420407, Retrieved from the Internet <URL:http://www.intervet.com/news/2005-11-21_-_intervet_to_support_european_zoos.asp> [retrieved on 20070215] *
KARACA KEMAL ET AL: "Immunogenicity of fowlpox virus expressing the avian influenza virus H5 gene (TROVAC AIV-H5) in cats", CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, vol. 12, no. 11, November 2005 (2005-11-01), pages 1340 - 1342, XP002434626, ISSN: 1071-412X *
KATZ J M ET AL: "EFFICACY OF INACTIVATED INFLUENZA A VIRUS (H3N2) VACCINES GROWN IN MAMMALIAN CELLS OR EMBRYONATED EGGS", JOURNAL OF INFECTIOUS DISEASES, CHICAGO, IL, US, vol. 160, no. 2, August 1989 (1989-08-01), pages 191 - 198, XP009052851, ISSN: 0022-1899 *
KUIKEN THIJS ET AL: "Avian H5N1 influenza in cats.", SCIENCE 8 OCT 2004, vol. 306, no. 5694, 8 October 2004 (2004-10-08), pages 241, XP002473277, ISSN: 1095-9203 *
LU XIUHUA ET AL: "Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses", VACCINE, vol. 24, no. 44-46, 5 June 2006 (2006-06-05), pages 6588 - 6593, XP002420313, ISSN: 0264-410X *
PALKER T ET AL: "Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants", VIRUS RESEARCH, AMSTERDAM, NL, vol. 105, no. 2, October 2004 (2004-10-01), pages 183 - 194, XP004559736, ISSN: 0168-1702 *
TENGERDY R P ET AL: "VITAMIN E ADJUVANT FORMULATIONS IN MICE", VACCINE, vol. 9, no. 3, 1991, pages 204 - 206, XP002473276, ISSN: 0264-410X *

Also Published As

Publication number Publication date
WO2008059018A2 (fr) 2008-05-22

Similar Documents

Publication Publication Date Title
EP2452693A3 (fr) Vaccins et methodes permettant de traiter la grippe canine
EP2078083A4 (fr) Nouveau virus de la grippe canine et vaccin correspondant
NO20075961L (no) Materialer og fremgangsmater til kontroll av respiratorisk sykdom hos hundedyr
WO2006115843A3 (fr) Vaccins contre le virus nipah
WO2008076915A3 (fr) Traitement des porcs avec l&#39;antigène du pcv2
BRPI0519135A2 (pt) macrolÍdeos
WO2008073891A3 (fr) Vaccin contre salmonella
WO2007024947A3 (fr) Vaccins contre la grippe canine
BR112012000515A2 (pt) substrato, formulação aquosa, métodos para proteger seres humanos e/ou animais domésticos, e para combater insetos nocivos em uma construção, e, uso de um substrato.
BRPI0811499A2 (pt) Métodos para purificar um vírus ou antígeno viral, e para preparar uma vacina contra um vírus ou antígeno viral.
WO2007140244A3 (fr) Vaccination d&#39;animaux jeunes contre des infections par lawsonia intracellularis
Bosco‐Lauth et al. Shedding of clade 2.3. 4.4 H5N8 and H5N2 highly pathogenic avian influenza viruses in peridomestic wild birds in the US
WO2007036735A3 (fr) Agents immunogenes
WO2008059018A3 (fr) Vaccin pour vacciner des espèces félines et canines contre le virus de la grippe
DE112007002677A5 (de) Tierleine, insbesondere Hundeleine
WO2008157203A3 (fr) Procédés pour protéger des animaux de l&#39;infection par la grippe aviaire
BRPI0811202A2 (pt) Uso de compostos, composição agrícola , métodos para controlar pragas de animal e para tratar ou proteger um animal da infestação ou infecção por parasitas, semente, e, compostos.
WO2008115785A3 (fr) Vaccins polyvalents pour la grippe aviaire et procédés
WO2009097291A3 (fr) Vaccins contre la grippe canine
Masters HPAI as part of a zoological collection's preventive medicine programme: experience at ZSL in 2016/2017.
BRPI0918298A2 (pt) Compostos de pirrolin-2-ilamino, método para controlar pragas de animais, material de propagação vegetal, método para tratar ou proteger um animal da infestação ou infecção pelos parasitas, e, uso dos compostos de pirrolin-2-ilamino.
National Association of State Public Health Veterinarians Compendium of animal rabies prevention and control, 2006: National Association of State Public Health Veterinarians, Inc.(NASPHV)
of Agriculture Measures to control an imported case of canine rabies in France
Filipič et al. HuIFN-Alpha N3 and PoIFN-Beta affect the replication of Avian Influenza (H5N2) virus in the embryonated chicken egg
Influenza Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07847175

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07847175

Country of ref document: EP

Kind code of ref document: A2